NAD+: The Cell’s Energy Currency—and Why It Matters

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

What is NAD+?

Nicotinamide adenine dinucleotide (NAD⁺) is a small molecule present in every living cell. Chemically, it’s two nucleotides joined together (NMN + AMP). Biologically, it’s indispensable: cells use the oxidized form NAD⁺ and the reduced form NADH to shuttle electrons in thousands of redox reactions that power life.

How NAD+ Works

Think of NAD⁺/NADH as a rechargeable battery passed from enzyme to enzyme:

• Redox coenzyme: In glycolysis, the TCA cycle, and the electron transport chain, NAD⁺ accepts electrons (becoming NADH); NADH later donates them to make ATP. Without enough NAD⁺, energy production stalls.
• Cosubstrate for “NAD-consuming” enzymes:
  • Sirtuins (SIRT1–7): Use NAD⁺ to regulate gene expression, mitochondrial function, DNA repair, and circadian rhythm.
    
  • PARPs: Spend NAD⁺ to poly(ADP-ribosyl)ate proteins during DNA repair.
    
  • CD38/CD157: Hydrolyze NAD⁺ while modulating calcium and immune signaling.
    

Because these enzymes consume NAD⁺, cellular levels must be continually replenished.

Where NAD+ Comes From

Cells maintain NAD⁺ via three routes:

• Salvage pathway (dominant in most tissues): Recycles nicotinamide (NAM) back to NAD⁺ via NAMPT → NMN → NAD⁺.
  
• Preiss–Handler pathway: Converts nicotinic acid (NA) to NAD⁺.
  
• De novo pathway: Builds NAD⁺ from tryptophan (kynurenine pathway).
  

Why NAD+ Declines with Age

Multiple headwinds lower NAD⁺ as we get older:

• Increased consumption: Chronic DNA damage activates PARPs; inflammaging and immune activation upregulate CD38—both drain NAD⁺ reserves.
  
• Reduced synthesis: NAMPT declines with age and circadian disruption.
  
• Greater demand: Stressed mitochondria and genome maintenance increase sirtuin activity, further pulling on the NAD⁺ pool.
  

The result: impaired mitochondrial function, weaker stress responses, and accumulated cellular damage.

What the Research Shows (high level)

• Aging & longevity: Restoring NAD⁺ in model organisms improves metabolic health and, in some cases, extends lifespan. Human data so far show reliable NAD⁺ boosting with precursors, but clinical outcome benefits remain under active study.
  
• Muscle: Higher NAD⁺ supports mitochondrial biogenesis and exercise capacity in animals; NAD⁺ decline correlates with impaired regeneration during aging.
  
• Metabolic disorders: In rodents, NAD⁺ repletion counters diet-induced obesity, insulin resistance, and fatty liver. Early trials in humans show biochemical improvements; efficacy for disease endpoints is still being tested.
  
• Heart: In preclinical models, replenishing NAD⁺ limits ischemia–reperfusion injury, restrains pathological hypertrophy, improves conduction stability, and supports mitochondrial resilience.
  
• Brain: In models of neurodegeneration and stroke, NAD⁺ augmentation bolsters neuronal stress resistance, mitophagy, and synaptic function; translation to human outcomes is ongoing.
  

Ways Scientists Raise NAD+ (research context)

• Precursors: NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) reliably increase tissue NAD⁺ in animals and humans; NA and NAM also feed NAD⁺ pathways but have different tolerability/biological profiles.
  
• Enzyme targeting: Enhancing NAMPT activity or inhibiting CD38 preserves NAD⁺ (largely preclinical).
  
• Lifestyle signals: Exercise, caloric restriction, and robust circadian cues naturally favor NAD⁺ homeostasis and sirtuin signaling.

Important: While NAD⁺ boosters raise NAD⁺ levels in humans, who benefits, by how much, and for which conditions remains an area of active clinical research.

Safety & Caveats

• NAD⁺ metabolism touches DNA repair, immunity, and mitochondrial function; context matters (e.g., unchecked PARP activation depletes NAD⁺, but PARPs are essential for repair).
  
• Most compelling benefits come from animal studies; human trials to date are generally small and focused on biomarkers rather than hard outcomes.
  
• People with medical conditions or on multiple medications should discuss NAD⁺-related supplements with a clinician.

Bottom line

NAD⁺ is both fuel-handling hardware (redox coenzyme) and systems software (cofactor for sirtuins, PARPs, CD38) that keeps metabolism, DNA repair, and cellular timing in sync. Its age-related decline likely contributes to multi-organ vulnerability. Restoring NAD⁺ is a biologically plausible strategy with strong preclinical support and promising—but still preliminary—human evidence.

References 

• Imai S, Guarente L. NAD⁺ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464–471.
• Goody MF, Henry CA. A need for NAD⁺ in muscle development, homeostasis, and aging. Skeletal Muscle. 2018;8:9.
• Okabe K, Yaku K, Tobe K, Nakagawa T. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci. 2019;26:34.
• Xu W, Li L, Zhang L. NAD⁺ metabolism as a therapeutic target for CVD. Front Physiol. 2020;11:901.
• Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD⁺ in brain aging and neurodegenerative disorders. Cell Metab. 2019;30(4):630–655.